Keith K. H. Chan

1.4k total citations
63 papers, 1.2k citations indexed

About

Keith K. H. Chan is a scholar working on Pharmacology, Spectroscopy and Molecular Biology. According to data from OpenAlex, Keith K. H. Chan has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Spectroscopy and 14 papers in Molecular Biology. Recurrent topics in Keith K. H. Chan's work include Analytical Chemistry and Chromatography (14 papers), Drug Solubulity and Delivery Systems (8 papers) and Analytical Methods in Pharmaceuticals (8 papers). Keith K. H. Chan is often cited by papers focused on Analytical Chemistry and Chromatography (14 papers), Drug Solubulity and Delivery Systems (8 papers) and Analytical Methods in Pharmaceuticals (8 papers). Keith K. H. Chan collaborates with scholars based in United States, Switzerland and Hong Kong. Keith K. H. Chan's co-authors include V. A. John, Milo Gibaldi, Ronald J. Sawchuk, Shekman Wong, Parviz Mojaverian, Ronald C. Li, Charles Denaro, Peyton Jacob, N L Benowitz and Kenneth D. Brandt and has published in prestigious journals such as Macromolecules, Spine and Journal of Controlled Release.

In The Last Decade

Keith K. H. Chan

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith K. H. Chan United States 22 247 220 185 180 167 63 1.2k
A. Sioufi Switzerland 23 209 0.8× 273 1.2× 196 1.1× 91 0.5× 303 1.8× 73 1.5k
William H. Barr United States 24 309 1.3× 274 1.2× 282 1.5× 422 2.3× 115 0.7× 60 1.7k
Gilles Caillé Canada 20 135 0.5× 357 1.6× 128 0.7× 81 0.5× 162 1.0× 73 1.1k
L Balant Switzerland 26 395 1.6× 370 1.7× 257 1.4× 169 0.9× 201 1.2× 85 1.9k
J. Godbillon Switzerland 24 107 0.4× 286 1.3× 168 0.9× 222 1.2× 255 1.5× 61 1.3k
J.J. Vallner United States 15 399 1.6× 139 0.6× 159 0.9× 76 0.4× 194 1.2× 46 941
Mario Eandi Italy 18 199 0.8× 124 0.6× 131 0.7× 134 0.7× 86 0.5× 55 879
Frits Moolenaar Netherlands 21 425 1.7× 121 0.6× 194 1.0× 172 1.0× 55 0.3× 68 1.3k
Lawrence S. Olanoff United States 17 123 0.5× 141 0.6× 91 0.5× 162 0.9× 158 0.9× 27 823
G. Lockwood United States 19 233 0.9× 244 1.1× 521 2.8× 63 0.3× 137 0.8× 44 1.3k

Countries citing papers authored by Keith K. H. Chan

Since Specialization
Citations

This map shows the geographic impact of Keith K. H. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith K. H. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith K. H. Chan more than expected).

Fields of papers citing papers by Keith K. H. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith K. H. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith K. H. Chan. The network helps show where Keith K. H. Chan may publish in the future.

Co-authorship network of co-authors of Keith K. H. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Keith K. H. Chan. A scholar is included among the top collaborators of Keith K. H. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith K. H. Chan. Keith K. H. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Keith K. H., et al.. (2008). Pharmacokinetic and Pharmacodynamic Characterization of Non-antiarrhythmic QT-Prolonging Drugs Associated with Torsades de Pointes. Drug Information Journal. 42(3). 211–219. 4 indexed citations
2.
Cheung, Kmc, et al.. (2003). A new halo-pelvic apparatus. Spine. 28(3). 305–308. 1 indexed citations
3.
Lesko, L J, et al.. (1996). Bioequivalence assessment of generic drugs: an American point of view. European Journal of Drug Metabolism and Pharmacokinetics. 21(2). 159–164. 21 indexed citations
4.
Cheung, Wing K., et al.. (1995). Intra- and Inter-Subject Variabilities of CGP 33101 after Replicate Single Oral Doses of Two 200-mg Tablets and 400-mg Suspension. Pharmaceutical Research. 12(12). 1878–1882. 19 indexed citations
5.
Li, Ronald C., Shekman Wong, & Keith K. H. Chan. (1995). Microcomputer-Based Programs for Pharmacokinetic Simulations. American Journal of Pharmaceutical Education. 59(2). 143–147. 30 indexed citations
6.
7.
Lu, Hai‐Lin, et al.. (1995). A Novel Multivariate Approach for Estimating the Degree of Similarity in Bioavailability between Two Pharmaceutical Products. Journal of Pharmaceutical Sciences. 84(6). 768–772. 2 indexed citations
8.
Morgan, John, et al.. (1994). APPLICATION OF A STABLE ISOTOPE TECHNIQUE FOR THE BIOEQUIVALENCY STUDY OF TWO TRANSDERMAL NITROGLYCERIN SYSTEMS. American Journal of Therapeutics. 1(1). 15–21. 3 indexed citations
9.
Chan, Keith K. H., et al.. (1994). Effect of Food on the Relative Bioavailability of a Hypolipidemic Agent (CGP 43371) in Healthy Subjects. Journal of Pharmaceutical Sciences. 83(2). 264–266. 5 indexed citations
10.
Elmquist, William F., Keith K. H. Chan, & Ronald J. Sawchuk. (1994). Transsynovial Drug Distribution: Synovial Mean Transit Time of Diclofenac and Other Nonsteroidal Antiinflammatory Drugs. Pharmaceutical Research. 11(12). 1689–1697. 27 indexed citations
11.
Chan, Keith K. H., et al.. (1993). Urinary Excretion of Aminohydroxypropylidene Bisphosphonate in Cancer Patients after Single Intravenous Infusions. Journal of Pharmaceutical Sciences. 82(6). 665–667. 8 indexed citations
12.
DeAngelis, Lisa M., et al.. (1992). Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside. Cancer Chemotherapy and Pharmacology. 29(3). 173–177. 30 indexed citations
13.
Chan, Keith K. H., et al.. (1991). Pharmacokinetics of Multiple Daily Transdermal Doses of Nicotine in Healthy Smokers. Pharmaceutical Research. 8(3). 385–388. 20 indexed citations
14.
Benowitz, N L, Keith K. H. Chan, Charles Denaro, & Peyton Jacob. (1991). Stable isotope method for studying transdermal drug absorption: The nicotine patch. Clinical Pharmacology & Therapeutics. 50(3). 286–293. 70 indexed citations
15.
Kreis, Willi, Keith K. H. Chan, Steven L. Allen, et al.. (1991). Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot study.. PubMed. 5(11). 991–8. 20 indexed citations
16.
Chan, Keith K. H. & Milo Gibaldi. (1990). Effects of First-Pass Metabolism on Metabolite Mean Residence Time Determination After Oral Administration of Parent Drug. Pharmaceutical Research. 7(1). 59–63. 8 indexed citations
17.
Chan, Keith K. H., D. R. Budman, Philip Schulman, et al.. (1988). Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours.. PubMed. 48(5). 1337–42. 34 indexed citations
18.
Chan, Keith K. H., et al.. (1987). Microcomputer-based programs for calculating mean and variance residence time by the method of prospective areas. Computer Methods and Programs in Biomedicine. 25(1). 23–30. 2 indexed citations
19.
Hui, Koon‐Sea, et al.. (1985). Separation of enkephalins from their metabolites and precursor by a single pump gradient high-performance liquid chromatographic method. Journal of Chromatography A. 325(2). 467–472. 3 indexed citations
20.
Chan, Keith K. H., et al.. (1983). Microcomputer based pharmacokinetic programs for calculating absorption rate. Computer Programs in Biomedicine. 16(1-2). 27–33. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Sioufi Breakdown of academic impact, for papers by William H. Barr Breakdown of academic impact, for papers by Gilles Caillé Breakdown of academic impact, for papers by L Balant Breakdown of academic impact, for papers by J. Godbillon Breakdown of academic impact, for papers by J.J. Vallner Breakdown of academic impact, for papers by Mario Eandi Breakdown of academic impact, for papers by Frits Moolenaar Breakdown of academic impact, for papers by Lawrence S. Olanoff Breakdown of academic impact, for papers by G. Lockwood
Rankless by CCL
2026